Inclusion body refolding optimization is the single most impactful step in recovering active recombinant protein from E. coli. About 30% of all recombinant proteins expressed in E. coli form inclusion bodies, and for complex targets with multiple disulfide bonds, the figure approaches 100%. While inclusion bodies offer the advantage of high purity (50-90% target protein), the refolding step is where yield is won or lost. This guide covers every variable that determines refolding success: solubilization chemistry, buffer additive selection, DOE-based optimization, method selection for your scale, and the engineering challenges of manufacturing-scale refolding.
Why Refolding Is the Yield-Limiting Step
Refolding is the rate-limiting step in inclusion body processing because the protein must navigate a complex energy landscape from a fully unfolded state back to a single native conformation. Typical unoptimized refolding yields range from 10-40%, meaning 60-90% of the expressed protein is lost to aggregation, misfolding, or incomplete disulfide bond formation.
The core problem is kinetic competition. When the denaturant is removed, two pathways compete: correct folding (first-order kinetics, proportional to protein concentration) and aggregation (second- or higher-order kinetics, proportional to concentration squared or higher). At higher protein concentrations, aggregation wins. This is why dilution refolding requires protein concentrations below 0.1-0.5 mg/mL.
Three factors dominate refolding yield:
- Protein concentration during refolding: lower is better, but too low wastes buffer and tank volume
- Denaturant removal rate: too fast traps misfolded intermediates; too slow allows aggregation at intermediate chaotrope levels
- Buffer composition: pH, redox environment, and aggregation suppressors (especially L-arginine) determine whether intermediates fold correctly or aggregate
With systematic DOE-based optimization of these factors, refolding yields of 60-80% are achievable for many proteins. Several approved biologics, including insulin (Humulin), interferon-beta (Betaferon), and growth hormone (somatropin), are manufactured from E. coli inclusion bodies with optimized refolding processes.
Solubilization Chemistry: Choosing the Right Denaturant
The choice of denaturant during solubilization directly affects refolding outcome because it determines how much native-like structure the protein retains. Full denaturation (6 M GdnHCl or 8 M urea) produces a random coil that must refold from scratch, while mild solubilization preserves secondary structure elements that guide the protein toward its native state.
| Agent | Concentration | Mechanism | Structure Preserved | Best For |
|---|---|---|---|---|
| Guanidine HCl | 6 M | Ionic chaotrope; disrupts hydrophobic core and H-bonds | None (random coil) | Disulfide-rich proteins needing complete unfolding |
| Urea | 8 M | Non-ionic chaotrope; disrupts H-bonds and hydrophobic interactions | Minimal | Proteins without disulfide bonds; IEX-compatible |
| Urea (mild) | 2-4 M | Partial unfolding; disrupts intermolecular contacts | Significant secondary structure | Proteins with residual native-like IB structure |
| Sarkosyl (NLS) | 0.3-2% w/v | Anionic detergent; disrupts hydrophobic aggregates | Some secondary structure | Membrane-associated or hydrophobic proteins |
| Alkaline pH | pH 12-12.5 | Charge repulsion; disrupts electrostatic interactions | Variable | Proteins stable to brief alkaline exposure |
| N-propanol | 10-30% v/v | Organic solvent; disrupts hydrophobic aggregation | Alpha-helical structure | Helical proteins (e.g., growth hormones) |
GdnHCl vs. urea is the most common decision. GdnHCl at 6 M is a stronger denaturant that completely unfolds the polypeptide chain, which is necessary when incorrect disulfide bonds must be broken and re-formed. However, GdnHCl is ionic (contributes ~6 M to ionic strength) and must be removed before ion-exchange chromatography. Urea at 8 M is non-ionic and compatible with IEX, but it can carbamylate lysine residues if the solution is heated or aged (hydrolysis generates cyanate). Always prepare urea solutions fresh and deionize with mixed-bed resin.
Mild solubilization is gaining ground. Studies on several proteins have shown that 2-4 M urea can solubilize inclusion bodies while preserving secondary structure elements detected by circular dichroism and FTIR. One study reported that mild solubilization at 2 M urea retained native-like beta-sheet content and yielded active protein without a conventional refolding step. This approach works best when inclusion bodies have been formed at lower expression temperatures (25-30 °C) where they retain more native-like structure.
A reducing agent is added during solubilization to break any inter- or intra-molecular disulfide bonds. Common choices are 10-100 mM DTT, 10-100 mM beta-mercaptoethanol, or 5-20 mM TCEP (which is stable at low pH and does not interfere with thiol-disulfide exchange during subsequent refolding).
Refolding Methods Compared: Dilution, Dialysis, On-Column, and SEC
Five refolding methods are used in practice, each trading protein concentration capability against process complexity and buffer volume. Rapid dilution is simplest but requires the largest volumes; on-column refolding handles the highest concentrations but demands more development.
| Method | Max Protein Conc. | Buffer Volume (per g IB) | Typical Yield | Process Time | Scale Suitability |
|---|---|---|---|---|---|
| Rapid dilution | 0.05-0.2 mg/mL | 50-200 L | 20-50% | 1-4 h | Lab to pilot |
| Pulse (fed) dilution | 0.1-0.5 mg/mL | 20-80 L | 30-60% | 4-8 h | Pilot to manufacturing |
| Dialysis | 0.5-2 mg/mL | 3-10 L (3 buffer changes) | 25-55% | 12-48 h | Lab to pilot |
| On-column (IMAC/IEX) | Up to 10 mg/mL | 5-20 L (column + buffers) | 40-70% | 4-12 h | Lab to manufacturing |
| SEC-assisted | 1-5 mg/mL | 2-10 L | 30-60% | 2-6 h | Lab to pilot |
Rapid dilution is the most common laboratory method. The denatured protein is added in one step to a large volume of refolding buffer, instantly dropping the denaturant concentration. The critical parameter is the final protein concentration: above 0.2 mg/mL for most proteins, aggregation dominates. This simplicity comes at the cost of enormous buffer volumes at scale.
Pulse (fed) dilution adds the denatured protein in small aliquots (typically 5-10% of the refolding volume per pulse) over several hours. Each pulse allows the previously added protein to refold before the next addition, suppressing the concentration-dependent aggregation pathway. Pulse dilution can achieve the same final protein concentration with 40-60% less refolding buffer than batch dilution.
On-column refolding immobilizes the denatured protein on a chromatography column (IMAC for His-tagged proteins, IEX for charged proteins) and then exchanges the denaturant for refolding buffer via a gradient. The column matrix physically separates individual protein molecules, suppressing intermolecular aggregation. This allows refolding at concentrations up to 10 mg/mL, orders of magnitude higher than dilution methods. For consensus interferon, on-column HIC refolding improved specific activity 2.6-fold and soluble protein recovery by 30% compared with dilution.
Refolding Buffer Design: Additives That Matter
The refolding buffer determines whether the protein folds correctly, aggregates, or remains in a misfolded intermediate state. Six categories of additives influence the outcome, and the optimal combination is protein-specific.
| Category | Common Agents | Typical Concentration | Mechanism |
|---|---|---|---|
| Aggregation suppressor | L-arginine | 0.4-0.8 M | Increases solubility of intermediates; does not stabilize native state |
| Redox pair | GSH:GSSG (reduced:oxidized glutathione) | 1-5 mM total; ratio 5:1 to 10:1 | Enables disulfide bond shuffling to reach native pairings |
| Osmolyte / kosmotrope | Sucrose, glycerol, sorbitol, trehalose | 0.2-1.0 M (sucrose); 10-20% v/v (glycerol) | Stabilizes compact states via preferential exclusion |
| Mild detergent | CHAPS, Triton X-100, Tween 20 | 0.1-1% w/v (below CMC) | Shields hydrophobic surfaces on intermediates |
| Low residual chaotrope | Urea (0.5-2 M), GdnHCl (0.5-1 M) | Sub-denaturing | Slows folding to allow correct disulfide formation |
| Buffer / pH | Tris, HEPES, phosphate | 50-100 mM, pH 7.0-10.0 | Controls charge state and electrostatic interactions |
L-arginine is the single most important refolding additive. At 0.4-0.8 M, it suppresses aggregation by increasing the equilibrium solubility of partially folded intermediates without significantly stabilizing the native state. This selectivity is critical: stabilizing agents like sucrose drive the protein toward compact states, which can include misfolded aggregates, while arginine keeps intermediates soluble long enough for correct folding to occur.
Redox environment is essential for disulfide-containing proteins. The GSH:GSSG ratio controls the thiol-disulfide exchange equilibrium. A ratio of 5:1 (reduced:oxidized) at 1-5 mM total glutathione is a common starting point. The reduced form breaks incorrect disulfide bonds; the oxidized form drives formation of new ones. For proteins with many disulfide bonds (e.g., Fab fragments with 2 interchain and 2 intrachain bonds), optimizing this ratio is often the highest-impact single variable.
pH affects both the protein's charge state and the rate of disulfide exchange. Most refolding buffers operate at pH 8.0-9.5. Higher pH accelerates thiol-disulfide exchange (thiolate is the reactive species) but also promotes aggregation for some proteins. The optimum is protein-specific and should be included as a DOE factor.
How to Design a DOE Screen for Refolding Optimization
A design of experiments (DOE) approach is the most efficient route to optimizing refolding conditions, typically requiring 20-40 experiments to find a near-optimal buffer instead of the hundreds needed by one-factor-at-a-time screening. The screen proceeds in two stages: a broad factorial screen to identify significant factors, followed by a response surface design to find the optimum.
Stage 1: Screening Design (6-8 factors)
Use a fractional factorial (resolution IV) or Plackett-Burman design with 12-20 runs to screen these factors simultaneously:
- pH (7.0 - 10.0)
- Protein concentration (0.05 - 1.0 mg/mL)
- L-arginine (0 - 0.8 M)
- GSH:GSSG ratio (1:1 to 10:1, with total fixed at 2 mM)
- Residual denaturant (0 - 1.5 M urea)
- Osmolyte (0 - 0.5 M sucrose or sorbitol)
- Temperature (4 - 25 °C)
- Mild detergent (0 - 0.5% CHAPS)
Measure refolding yield as the primary response: SEC-HPLC monomer fraction (%) or bioactivity (% of reference standard). Include 3-4 center points for curvature detection and pure-error estimation.
Stage 2: Response Surface Optimization (3-4 factors)
From the screening results, take the 3-4 statistically significant factors (typically protein concentration, arginine, pH, and redox ratio) and run a central composite design (CCD) or Box-Behnken design (BBD) with 15-30 runs. This produces a polynomial model (usually second-order) that maps the response surface and identifies the optimum.
Design Your Refolding Screen
Use our free DOE Generator to build a factorial or response surface design for refolding buffer optimization. Select factors, set ranges, and get a randomized run order in seconds.
Worked Example: DOE Screen for scFv Refolding
Protein: Anti-VEGF scFv (28 kDa, 2 disulfide bonds), expressed in E. coli BL21(DE3) at 37 °C, solubilized in 6 M GdnHCl + 10 mM DTT.
Stage 1: Plackett-Burman design, 12 runs + 3 center points = 15 experiments. Significant factors (p < 0.05): protein concentration, L-arginine, GSH:GSSG ratio. Non-significant: temperature, detergent, osmolyte.
Stage 2: Box-Behnken design on 3 factors, 15 runs + 3 center points = 18 experiments.
Optimal conditions found:
- Protein concentration: 0.15 mg/mL
- L-arginine: 0.55 M
- GSH:GSSG: 5:1, 3 mM total
- pH: 8.5 (Tris-HCl)
- Residual GdnHCl: 0.5 M
- Temperature: 10 °C
Result: 68% refolding yield (monomer by SEC-HPLC), up from 22% with the initial unoptimized buffer (50 mM Tris pH 8.0, no additives). Total experiments: 33.
Aggregation Suppression: The Role of L-Arginine
L-arginine is the most broadly effective aggregation suppressor for protein refolding, used at 0.4-0.8 M in the majority of optimized refolding protocols. Its mechanism is distinct from stabilizing osmolytes: rather than favoring the compact native state, arginine increases the equilibrium solubility of unfolded intermediates and partially folded species.
The guanidinium group of arginine interacts with aromatic and charged residues on the protein surface, reducing the driving force for intermolecular association. Studies on recombinant plasminogen activator showed that transfer free energies for the native protein were lowered by up to 14 kJ/mol in the presence of L-arginine, and aggregation suppression increased with arginine concentration up to 0.5-1.0 M.
Critical points about arginine in refolding:
- Solubility is not activity. Above 0.5-0.8 M, arginine continues to increase protein solubility but may not improve biological activity. The optimum must be checked by activity assay, not just turbidity or SEC.
- Not universal. Some disulfide-rich proteins show no improvement with arginine. For these proteins, low concentrations of residual denaturant (0.5-1.5 M urea) or mild detergents may be more effective.
- Must be removed. Arginine at 0.4-0.8 M interferes with protein A, IEX, and some HIC steps. Plan a diafiltration or buffer exchange step before downstream purification.
Analytical Methods for Monitoring Refolding Yield
Refolding yield can only be optimized if it can be measured accurately and quickly enough to support a DOE screen. Three orthogonal methods are used, each measuring a different aspect of refolding success.
| Method | What It Measures | Throughput | Sample Volume | Limitations |
|---|---|---|---|---|
| SEC-HPLC | Monomer vs. aggregate ratio by size | 20-40 samples/day | 10-50 μL | Does not confirm native fold; co-eluting impurities |
| Bioactivity assay | Functional protein (enzyme activity, binding) | Varies (4-96 samples/day) | 1-100 μL | Protein-specific; slower; requires reference standard |
| DLS (dynamic light scattering) | Hydrodynamic radius; aggregation detection | 50-100 samples/day | 10-20 μL | Qualitative for aggregation; poor at low concentrations |
| Circular dichroism (CD) | Secondary structure content | 10-20 samples/day | 200-500 μL | Confirms fold but not activity; requires pure sample |
| Intrinsic fluorescence | Tertiary structure (Trp environment) | 50-100 samples/day | 10-100 μL | Requires Trp residues; non-quantitative |
For DOE screening, SEC-HPLC is the workhorse: it quantifies the monomer fraction in 15-30 minutes per sample, is automatable, and requires minimal sample. Use it as the primary response for DOE. Confirm the top 3-5 conditions from the DOE with a bioactivity assay to ensure that the SEC monomer is correctly folded and not a compact, inactive aggregate.
Scale-Up to Manufacturing: Tank Sizing, Mixing, and Heat Removal
Scaling refolding from laboratory to manufacturing introduces three engineering challenges that do not exist at bench scale: tank volume, mixing homogeneity during dilution, and heat management from exothermic refolding reactions.
Tank sizing for dilution refolding
Dilution refolding requires 50-100x the volume of the solubilized inclusion body solution. For a typical 500 L E. coli fermentation yielding 50 g/L wet cell weight and 5 g/L inclusion bodies, solubilization in 6 M GdnHCl at 20 mg/mL protein concentration produces 125 L of denatured protein. Diluting this 50-fold requires a 6,250 L refolding tank.
Worked Example: Manufacturing-Scale Refolding Tank Sizing
Starting point: 500 L fermentation, 2.5 kg inclusion bodies (wet), 1.25 kg protein after washing.
Solubilization: 1,250 g protein in 62.5 L of 6 M GdnHCl (20 mg/mL protein).
Rapid dilution (50x): 62.5 L × 50 = 3,125 L refolding buffer. Final protein: 0.4 mg/mL. Tank volume: 3,200 L (with headspace).
Pulse dilution (20x effective): Add denatured protein in 10 pulses of 6.25 L over 8 hours into 1,250 L refolding buffer. Final protein: 0.5 mg/mL at the end of each pulse before next addition allows partial refolding. Tank volume: 1,400 L. Volume saved: 55%.
On-column IMAC: Load 62.5 L onto a 10 L IMAC column (5 cm ID × 50 cm bed, 125 mg/mL capacity). Gradient refold over 20 column volumes (200 L total buffer). Tank volume: 250 L for buffer prep. Volume saved: 92%.
Yield comparison (same protein): Rapid dilution 45%, pulse dilution 58%, on-column 67%.
Mixing during dilution
Poor mixing at scale creates local high-concentration zones where aggregation is favored. For rapid dilution, the denatured protein should be added below the liquid surface near the impeller to ensure immediate mixing. For pulse dilution, a peristaltic pump feeding into the impeller zone at a controlled rate (typically 1-5 L/min for a 2,000 L tank) prevents concentration spikes. Mixing time should be less than 30 seconds at the refolding scale, which is achievable with a standard Rushton turbine at 50-100 rpm in a 2,000-4,000 L vessel.
Temperature control
Refolding is typically performed at 4-15 °C to slow aggregation kinetics relative to folding. At manufacturing scale, cooling 3,000+ L of buffer to 10 °C and maintaining that temperature during an 8-hour pulse dilution requires significant cooling capacity. Plan for 0.5-1.0 kW/m³ cooling, and ensure the jacket cooling medium can handle the heat of dilution from GdnHCl-containing solutions.
Generate Your Refolding Conditions
Use the Refolding Generator to screen solubilization and refolding buffer compositions for your target protein. Input your protein properties and get a starting protocol.
Frequently Asked Questions
What is a typical refolding yield for inclusion body proteins?
Unoptimized refolding yields typically range from 10-40% of the solubilized protein recovering biological activity. With systematic optimization using DOE-based buffer screening, yields of 60-80% are achievable for many proteins. The main yield losses come from aggregation during the refolding process, incomplete disulfide bond formation, and irreversible misfolding of kinetically trapped intermediates.
What concentration of L-arginine should I use for protein refolding?
L-arginine is typically used at 0.4-0.8 M for refolding, with 0.5 M being the most common starting concentration. Arginine suppresses aggregation by increasing the equilibrium solubility of unfolded intermediates rather than stabilizing the native state. Concentrations above 0.8 M can increase solubility without improving biological activity, so the optimum should be determined empirically for each protein.
Should I use urea or guanidine hydrochloride to solubilize inclusion bodies?
Use 6 M guanidine hydrochloride (GdnHCl) for complete unfolding when the protein needs to form disulfide bonds correctly, as it denatures more thoroughly. Use 8 M urea for proteins without disulfide bonds or when milder conditions preserve residual secondary structure that aids refolding. GdnHCl is ionic and must be removed before ion-exchange chromatography, while urea is non-ionic and compatible with more downstream steps.
How do I scale up dilution refolding to manufacturing?
Dilution refolding scales poorly because protein concentration must stay below 0.1-0.5 mg/mL to avoid aggregation, requiring 50-100x dilution volumes. At manufacturing scale (10-100 L solubilized IBs), this means 500-10,000 L refolding tanks. Pulse (fed) dilution reduces peak volume by 40-60% by adding solubilized protein in small boluses over 4-8 hours. Alternatively, on-column refolding on IMAC or IEX handles higher concentrations (up to 10 mg/mL) and combines refolding with purification.
How do I design a DOE screen for refolding buffer optimization?
Start with a fractional factorial or Plackett-Burman screening design covering 6-8 factors: pH (7-10), protein concentration (0.05-1.0 mg/mL), L-arginine (0-0.8 M), redox ratio (GSH:GSSG from 1:1 to 10:1), osmolyte type and concentration, denaturant residual level, and temperature (4-25 °C). Measure refolding yield by SEC-HPLC or activity assay. Follow the screen with a response surface design (CCD or BBD) on the 3-4 significant factors to find the optimum.
Related Calculators
Refolding Generator
Screen solubilization and refolding buffer compositions for your target protein. Generates starting conditions based on protein properties (MW, pI, disulfide bonds).
DOE Generator
Build factorial, Plackett-Burman, or response surface designs for refolding optimization. Set your factors and levels, get a randomized run table and analysis. DOE Pro adds D-optimal, split-plot, Bayesian optimization, and QbD reports.
Buffer Calculator
Calculate buffer recipes for refolding and downstream steps. Covers Tris, HEPES, phosphate, and more at your target pH, concentration, and volume.
Related Tools
- E. coli Expression Optimizer — Optimize IPTG induction, temperature, and expression conditions to reduce inclusion body formation
- Filtration Calculator — Size TFF membranes for concentrating refolded protein after dilution refolding
- Chromatography Calculator — Design the capture and polish steps following refolding
References
- Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact. 2015;14:41. doi:10.1186/s12934-015-0222-8
- Yamaguchi H, Miyazaki M. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies. Biomolecules. 2014;4(1):235-251. doi:10.3390/biom4010235
- Eiberle MK, Jungbauer A. Technical refolding of proteins: do we have freedom to operate? Biotechnol J. 2010;5(6):547-559. doi:10.1002/biot.201000001
- Tsumoto K, Ejima D, Kumagai I, Arakawa T. Practical considerations in refolding proteins from inclusion bodies. Protein Expr Purif. 2003;28(1):1-8. doi:10.1016/S1046-5928(02)00641-1
- Upadhyay V, Singh A, Jha D, Singh A, Panda AK. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent. Microb Cell Fact. 2016;15:100. doi:10.1186/s12934-016-0504-9